> Details

Salomone, Federico; Petta, Salvatore; Micek, Agnieszka; Pipitone, Rosaria Maria; Distefano, Alfio; Castruccio Castracani, Carlo; Rini, Francesca; Di Rosa, Michelino; Gardi, Concetta; Calvaruso, Vincenza; Di Marco, Vito; Li Volti, Giovanni; Grimaudo, Stefania; Craxì, Antonio

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis
  • Contributor: Salomone, Federico; Petta, Salvatore; Micek, Agnieszka; Pipitone, Rosaria Maria; Distefano, Alfio; Castruccio Castracani, Carlo; Rini, Francesca; Di Rosa, Michelino; Gardi, Concetta; Calvaruso, Vincenza; Di Marco, Vito; Li Volti, Giovanni; Grimaudo, Stefania; Craxì, Antonio
  • imprint: Wiley, 2020
  • Published in: Liver International
  • Language: English
  • DOI: 10.1111/liv.14608
  • ISSN: 1478-3223; 1478-3231
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and aims</jats:title><jats:p>HCV eradication improves non‐hepatic outcomes such as cardiovascular diseases, although without clearly defined mechanisms. In this study we aimed to assess whether improvement of carotid atherosclerosis may be linked to a reduction in systemic oxidative stress after viral clearance.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We studied a retrospective cohort of 105 patients (age 62.4 ± 11.2 years; 62 men) with F3/F4 fibrosis, characterized by carotid ultrasonography at baseline and at sustained virologic response (SVR) follow‐up. Levels of 8‐iso‐prostaglandin F<jats:sub>2α</jats:sub> (F<jats:sub>2</jats:sub>‐isoprostanes) and other oxidative stress markers were measured on frozen sera. Association between change (denoted as Δ) in oxidative stress markers (exposures) and change in carotid intima‐media thickness (cIMT) (outcome) was examined using multiple linear regression.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Subclinical atherosclerosis, defined as the presence of carotid plaque and/or cIMT ≥ 0.9, was present in 72% of the cohort. All patients achieved SVR that led to reduction in cIMT (0.92 ± 0.20 vs 0.83 ± 0.21 mm, <jats:italic>P</jats:italic> &lt; .001). HCV eradication markedly decreased serum levels of F<jats:sub>2</jats:sub>‐isoprostanes (620.5 [143.2; 1904.1] vs 119.51 [63.2; 400.6] pg/mL, <jats:italic>P</jats:italic> &lt; .0001), lipid hydroperoxides (13.8 [6.3; 20.7] vs 4.9 [2.3; 9.6] nmol/μl, <jats:italic>P</jats:italic> &lt; .0001) and 8‐hydroxy‐2'‐deoxyguanosine (558.9 [321.0; 6301.2] vs 294.51 [215.31; 408.95] pg/mL, <jats:italic>P</jats:italic> &lt; .0001), whereas increased serum GPx activity (10.44 [4.6; 16.3] vs 13.75 [9.42; 20.63] nmol/min/mL, <jats:italic>P</jats:italic> = .001). By multiple linear regression analysis ΔcIMT was independently associated with ΔF<jats:sub>2</jats:sub>‐isoprostanes (β: 1.746 [0.948; 2.543]; <jats:italic>P</jats:italic> &lt; .0001) after adjustment for age, baseline F<jats:sub>2</jats:sub>‐isoprostanes and baseline IMT.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Besides association of lipid peroxidation with severity of liver disease, the reduction in F<jats:sub>2</jats:sub>‐isoprostanes may be involved in the improvement of atherosclerosis after HCV eradication.</jats:p></jats:sec>